US technology stocks continue to dominate Wall Street in 2024. But as the year draws to a close, there are signs of a shift in investor preferences. While chipmakers have underperformed in recent weeks, software companies have been in demand.

As the year draws to a close, the Swiss equity market looks set to end on a positive note. However, the performance of individual stocks is very mixed. 

US retailers are entering the most important season of the year. The business environment is likely to be challenging as US inflation remains elevated and consumer sentiment is muted.

The economic outlook for Germany is deteriorating towards the end of the year. Despite this, the German stock market has performed remarkably well this year. 

Donald Trump's pick for the Department of Health and Human Services has sent healthcare stocks tumbling. The consequences are also being felt on the Swiss stock exchange. 

Wall Street closed at a new all-time high following Donald Trump's election victory. However, not all sectors benefit from the president-elect's likely economic agenda. 

Investors have yet to digest US pharmaceutical giant Eli Lilly's disappointing quarterly results. Shares remain under pressure after its appetite suppressants failed to meet high sales expectations. However, demand for the drugs appears to remain strong.

In about a week, Americans will elect their next president. This will mark the end of an emotional and turbulent election campaign. However, investors would be well advised to keep a cool head and make their investment decisions independently of political considerations. The ZKB Capital Protection Certificate allows you to participate fully in the S&P 500 Index, provided that the knock-out level of 120% is not reached.

The Chinese government is increasing its efforts to tackle the country's economic slowdown. However, initial enthusiasm in financial markets has faded. For investors, the situation opens up investment opportunities.